Back to News List
Industry News

Precision-Targeting Androgenic Alopecia: The Strategy & Breakthrough of PHMO's Anti-Androgen APIs

2025年11月24日
2
Precision-Targeting Androgenic Alopecia: The Strategy & Breakthrough of PHMO's Anti-Androgen APIs

At PHMO, we are reshaping the fight against androgenetic alopecia with our cutting-edge anti-androgen portfolio. Our ingredients target the root cause—the damaging effects of Dihydrotestosterone (DHT), empowering formulators with diverse solutions from personal care to pharmaceutical grades.

Anti-Hair Loss Product Catalog.pdf


Three Precision Tools for a Comprehensive Solution

RU-58841 | Next-Gen Topical Receptor Blocker

Mechanism: This novel topical anti-androgen competitively blocks androgen receptors directly within hair follicles, precisely neutralizing DHT's damaging signals to halt hair loss and stimulate follicle regeneration.

Application: Designed for topical use (e.g., serums, lotions). Its exceptional receptor affinity and prolonged 48-hour activity support effective once-daily application, offering a potent solution without systemic impact.

Finasteride | The Oral Gold Standard for Systemic Control

Mechanism: An FDA-approved, clinically proven cornerstone. As a potent 5α-reductase inhibitor, it systemically reduces DHT levels in the scalp and serum, fundamentally reversing the follicular miniaturization process.

Application: Standard 1mg daily oral tablet. Supported by extensive clinical data showing sustained effects in over 80% of long-term users, representing a highly reliable systemic control option.

Clascoterone | Targeted & Safe Topical Solution

Mechanism: This ingredient elevates topical therapy. As a targeted androgen receptor inhibitor, it directly binds to and blocks receptors in follicles, inhibiting DHT signaling without systemic absorption risks.

Application: Suitable for topical application (e.g., creams, gels). Its safety profile, already established in topical acne treatment, ensures excellent skin tolerability, making it an ideal choice for safety-conscious, precision-targeted formulations.

Technology Evolution Path
From the persistent topical blockade pioneered by RU-58841, to the gold-standard systemic inhibition of Finasteride, and advancing to the safe, targeted therapy enabled by Clascoterone, PHMO's anti-androgen series offers a complete, tiered solution from foundational to advanced care.

Ideal for: Male/Female Androgenetic Alopecia, Scalp Serums, Hair Growth Tonics, Custom Oral Treatments.

Featured Products